MDM4 and cancer: Its function is commonly lost in cancers by mutations in the p53 gene or by overexpression of cellular inhibitory proteins Mdm2 and MdmX (also known as Mdm4 or HdmX) that cooperate to inhibit p53-mediated transcription by binding to its transactivation domain and by targeting p53 for proteasomal degradation [2].